Curaleaf Holdings, Inc. is 1.1x more valuable than Definium Therapeutics, Inc. by market capitalization ($2.85 B vs $2.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DFTX | CURLF |
|---|---|---|
| Market cap | $2.53 B | $2.85 B |
| US-listed rank | #1936 | #1848 |
| Revenue (latest FY) | - | $1.27B |
| Net income (latest FY) | -$183.79M | -$231.07M |
| Net margin | - | -18.2% |
| SEC filings | 445 | 176 |
Curaleaf Holdings, Inc. is 1.1x more valuable than Definium Therapeutics, Inc. by market capitalization ($2.85 B vs $2.53 B).
Full pages: Definium Therapeutics, Inc. and Curaleaf Holdings, Inc., or browse the full rankings.